Literature DB >> 7648979

Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether.

J Pauletzki1, J Holl, M Sackmann, M Neubrand, U Klueppelberg, T Sauerbruch, G Paumgartner.   

Abstract

To determine the rate and characteristics of gallstone recurrence after direct contact dissolution with methyl tert-butyl ether, 60 consecutive patients were followed for up to 4.5 years (median 2.2 years) after complete disappearance of all stone residues and debris and cessation of adjuvant bile acid therapy. Initial gallstones had been multiple in all but four patients. Twenty-eight of the 60 patients developed recurrent gallstones. The cumulative risk of gallstone recurrence (actuarial analysis) was 23 +/- 6%, 34 +/- 7%, 55 +/- 8%, and 70 +/- 9% at one, two, three, and four years, respectively. The recurrent stones were usually multiple and small (6 +/- 4 mm). Gallstone recurrence was associated with recurrent biliary pain in two patients, one of whom developed acute cholecystitis. Recurrent stones were cleared completely by bile acid medication with or without shock-wave lithotripsy in 61 +/- 15% of patients at one year (actuarial analysis). In conclusion, gallstone recurrence after successful contact dissolution of multiple stones with methyl tert-butyl ether has to be expected in a high percentage of patients. Most patients, however, remain free of biliary pain during long-term follow-up.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648979     DOI: 10.1007/bf02212701

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.

Authors:  P H Broomfield; R Chopra; R C Sheinbaum; G G Bonorris; A Silverman; L J Schoenfield; J W Marks
Journal:  N Engl J Med       Date:  1988-12-15       Impact factor: 91.245

2.  Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations.

Authors:  M J Allen; T J Borody; T F Bugliosi; G R May; N F LaRusso; J L Thistle
Journal:  N Engl J Med       Date:  1985-01-24       Impact factor: 91.245

3.  Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.

Authors:  K A Hood; D Gleeson; D C Ruppin; R H Dowling
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

4.  Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment.

Authors:  N Villanova; F Bazzoli; F Taroni; R Frabboni; G Mazzella; D Festi; L Barbara; E Roda
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

5.  Gallstone recurrence after medical dissolution. An overestimated threat?

Authors:  A Lanzini; R P Jazrawi; R M Kupfer; D P Maudgal; A E Joseph; T C Northfield
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

6.  Low-dose chenodiol to prevent gallstone recurrence after dissolution therapy.

Authors:  J W Marks; S P Lan; R A Baum; R L Habig; R F Hanson; T Hersh; N C Hightower; A F Hofmann; J M Lachin; E C Lasser
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

7.  Can aspirin prevent gallstone recurrence after successful extracorporeal shockwave lithotripsy?

Authors:  H E Adamek; A Buttmann; J Weber; J F Riemann
Journal:  Scand J Gastroenterol       Date:  1994-04       Impact factor: 2.423

8.  The Munich Gallbladder Lithotripsy Study. Results of the first 5 years with 711 patients.

Authors:  M Sackmann; J Pauletzki; T Sauerbruch; J Holl; G Schelling; G Paumgartner
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

9.  Combined treatment of symptomatic gallbladder stones by extracorporeal shock-wave lithotripsy (ESWL) and instillation of methyl tert-butyl ether (MTBE).

Authors:  J Holl; T Sauerbruch; M Sackmann; J Pauletzki; G Paumgartner
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

10.  Low early gallstone recurrence rate after successful extracorporeal lithotripsy in patients with solitary stones.

Authors:  G Pelletier; R Capdeville; H Mosnier; J M Raymond; J Delmont; J Moreaux; M Guivarch; M Amouretti; F X Caroli; V G Levy
Journal:  J Hepatol       Date:  1992-09       Impact factor: 25.083

View more
  7 in total

1.  Successful topical dissolution of cholesterol gallbladder stones using ethyl propionate.

Authors:  A F Hofmann; A Amelsberg; O Esch; C D Schteingart; K Lyche; H Jinich; E Vansonnenberg; H B D'Agostino
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  Outcome of gallbladder preservation in surgical management of primary bile duct stones.

Authors:  Ming-Guo Tian; Wei-Jin Shi; Xin-Yuan Wen; Hai-Wen Yu; Jing-Shan Huo; Dong-Feng Zhou
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 3.  Epidemiology, toxicokinetics, and health effects of methyl tert-butyl ether (MTBE).

Authors:  Scott Phillips; Robert B Palmer; Aaron Brody
Journal:  J Med Toxicol       Date:  2008-06

Review 4.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

5.  Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type?

Authors:  S P Pereira; S H Hussaini; C Kennedy; R H Dowling
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

6.  Therapy of gallstone disease: What it was, what it is, what it will be.

Authors:  Piero Portincasa; Agostino Di Ciaula; Leonilde Bonfrate; David Qh Wang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-04-06

Review 7.  Cholecystectomy versus no cholecystectomy in patients with silent gallstones.

Authors:  K S Gurusamy; K Samraj
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.